PUREfi Wealth LLC Takes $504,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

PUREfi Wealth LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 997 shares of the healthcare conglomerate’s stock, valued at approximately $504,000.

Several other institutional investors have also modified their holdings of the stock. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth about $37,000. Friedenthal Financial purchased a new position in shares of UnitedHealth Group in the third quarter worth about $51,000. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth about $55,000. Finally, Legacy Investment Solutions LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth about $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on UNH. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 1.4 %

NYSE UNH opened at $523.48 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The firm has a 50 day moving average of $523.63 and a two-hundred day moving average of $563.48.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.